» Articles » PMID: 36349655

Loss of Long-chain Acyl-CoA Synthetase 1 Promotes Hepatocyte Death in Alcohol-induced Steatohepatitis

Overview
Journal Metabolism
Specialty Endocrinology
Date 2022 Nov 9
PMID 36349655
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Alcohol consumption has been shown to disrupt hepatic lipid homeostasis. Long-chain acyl-CoA synthetase 1 (ACSL1) critically regulates hepatic fatty acid metabolism and lipid homeostasis by channeling fatty acids to lipid metabolic pathways. However, it remains unclear how ACSL1 contributes to the development of alcohol-associated liver disease (ALD).

Methods: We performed chronic alcohol feeding animal studies with hepatocyte-specific ACSL1 knockout (ACSL1) mice, hepatocyte-specific STAT5 knockout (STAT5) mice, and ACSL1 based-STAT5B overexpression (Stat5b-OE) mice. Cell studies were conducted to define the causal role of ACSL1 deficiency in the pathogenesis of alcohol-induced liver injury. The clinical relevance of the STAT5-ACSL1 pathway was examined using liver tissues from patients with alcoholic hepatitis (AH) and normal subjects (Normal).

Results: We found that chronic alcohol consumption reduced hepatic ACSL1 expression in AH patients and ALD mice. Hepatocyte-specific ACSL1 deletion exacerbated alcohol-induced liver injury by increasing free fatty acids (FFA) accumulation and cell death. Cell studies revealed that FFA elicited the translocation of BAX and p-MLKL to the lysosomal membrane, resulting in lysosomal membrane permeabilization (LMP) and thereby initiating lysosomal-mediated cell death pathway. Furthermore, we identified that the signal transducer and activator of transcription 5 (STAT5) is a novel transcriptional regulator of ACSL1. Deletion of STAT5 exacerbated alcohol-induced liver injury in association with downregulation of ACSL1, and reactivation of ACSL1 by STAT5 overexpression effectively ameliorated alcohol-induced liver injury. In addition, ACSL1 expression was positively correlated with STAT5 and negatively correlated with cell death was also validated in the liver of AH patients.

Conclusions: ACSL1 deficiency due to STAT5 inactivation critically mediates alcohol-induced lipotoxicity and cell death in the development of ALD. These findings provide insights into alcohol-induced liver injury.

Citing Articles

Acetylation of proximal cysteine-lysine pairs by alcohol metabolism.

McGinnis C, Harris P, Graham B, Marentette J, Michel C, Saba L Redox Biol. 2024; 79():103462.

PMID: 39729908 PMC: 11732177. DOI: 10.1016/j.redox.2024.103462.


Necroptosis in obesity: a complex cell death event.

Liu Z, Wang S, Wang W, Lv R, Sun C Apoptosis. 2024; 30(1-2):466-487.

PMID: 39702812 DOI: 10.1007/s10495-024-02055-z.


Hypoxia-Inducible Factor-2α Promotes Liver Fibrosis by Inducing Hepatocellular Death.

Mooli R, Mukhi D, Watt M, Nagati V, Reed S, Gandhi N Int J Mol Sci. 2024; 25(23).

PMID: 39684823 PMC: 11642083. DOI: 10.3390/ijms252313114.


Up-regulation of long non-coding RNA H19 ameliorates renal tubulointerstitial fibrosis by reducing lipid deposition and inflammatory response through regulation of the microRNA-130a-3p/long-chain acyl-CoA synthetase 1 axis.

Jiang Y, Ma F, Wang J, Chen X, Xue L, Chen X Noncoding RNA Res. 2024; 9(4):1120-1132.

PMID: 39022687 PMC: 11254502. DOI: 10.1016/j.ncrna.2024.05.002.


Nicotinamide mitigates visceral leishmaniasis by regulating inflammatory response and enhancing lipid metabolism.

Zhou Q, Zheng Z, Yin S, Duan D, Liao X, Xiao Y Parasit Vectors. 2024; 17(1):288.

PMID: 38971783 PMC: 11227177. DOI: 10.1186/s13071-024-06370-x.


References
1.
Gao B, Bataller R . Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology. 2011; 141(5):1572-85. PMC: 3214974. DOI: 10.1053/j.gastro.2011.09.002. View

2.
Baik M, Yu J, Hennighausen L . Growth hormone-STAT5 regulation of growth, hepatocellular carcinoma, and liver metabolism. Ann N Y Acad Sci. 2011; 1229:29-37. PMC: 3427656. DOI: 10.1111/j.1749-6632.2011.06100.x. View

3.
Ma Y, Zha J, Yang X, Li Q, Zhang Q, Yin A . Long-chain fatty acyl-CoA synthetase 1 promotes prostate cancer progression by elevation of lipogenesis and fatty acid beta-oxidation. Oncogene. 2021; 40(10):1806-1820. PMC: 8842993. DOI: 10.1038/s41388-021-01667-y. View

4.
Vuittonet C, Halse M, Leggio L, Fricchione S, Brickley M, Haass-Koffler C . Pharmacotherapy for alcoholic patients with alcoholic liver disease. Am J Health Syst Pharm. 2014; 71(15):1265-76. PMC: 4170837. DOI: 10.2146/ajhp140028. View

5.
Cui Y, Hosui A, Sun R, Shen K, Gavrilova O, Chen W . Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration. Hepatology. 2007; 46(2):504-13. DOI: 10.1002/hep.21713. View